Acute vasodilator effects of a Rho-kinase inhibitor, fasudil, in patients with severe pulmonary hypertension

Y Fukumoto; T Matoba; A Ito; H Tanaka; T Kishi; S Hayashidani; K Abe; A Takeshita; H Shimokawa

doi:10.1136/hrt.2003.029470

Article info

Scientific letters

Acute vasodilator effects of a Rho-kinase inhibitor, fasudil, in patients with severe pulmonary hypertension

Authors

Y Fukumoto Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan PubMed articles Google scholar articles
T Matoba Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan PubMed articles Google scholar articles
A Ito Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan PubMed articles Google scholar articles
H Tanaka Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan PubMed articles Google scholar articles
T Kishi Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan PubMed articles Google scholar articles
S Hayashidani Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan PubMed articles Google scholar articles
K Abe Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan PubMed articles Google scholar articles
A Takeshita Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan PubMed articles Google scholar articles
H Shimokawa Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan PubMed articles Google scholar articles

Correspondence to:
Dr Yoshihiro Fukumoto
3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan; yoshifcardiol.med.kyushu-u.ac.jp

View Full Text

Citation

Fukumoto Y, Matoba T, Ito A, et al

Acute vasodilator effects of a Rho-kinase inhibitor, fasudil, in patients with severe pulmonary hypertension

Heart 2005;91:391-392.

Publication history

Accepted May 14, 2004
First published February 14, 2005.

Online issue publication

January 09, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password